Zevra Therapeutics grants 53,000 shares of common stock to 3 new employees under Employment Inducement Award Plan.
CELEBRATION, Fla., December 12, 2025 - Zevra Therapeutics, Inc. (NasdaqGS: ZVRA), a company specializing in rare disease therapies, has announced the granting of Inducement Awards to new employees. These awards allow the purchase of 53,000 shares of the Company's common stock. The recipients will receive the shares over a four-year period, with 25% becoming available on the first anniversary of their start date, and the rest vesting in equal parts annually thereafter, contingent upon their continued employment.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments